Overview
Jacob Fischer-Lilja practices in Arhus, Denmark. Mr. Fischer-Lilja is rated as an Experienced expert by MediFind in the treatment of Hypercalcemia. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Cerebral Hypoxia, Human Papillomavirus Infection, Delayed Growth, and Parathyroidectomy.
His clinical research consists of co-authoring 16 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Hypercalcemia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Cerebral HypoxiaMr. Fischer-Lilja isAdvanced. Learn about Cerebral Hypoxia.
- Head and Neck Squamous Cell Carcinoma (HNSCC)Mr. Fischer-Lilja isAdvanced. Learn about Head and Neck Squamous Cell Carcinoma (HNSCC).
- Experienced
- Delayed GrowthMr. Fischer-Lilja isExperienced. Learn about Delayed Growth.
- Human Papillomavirus InfectionMr. Fischer-Lilja isExperienced. Learn about Human Papillomavirus Infection.
- HypercalcemiaMr. Fischer-Lilja isExperienced. Learn about Hypercalcemia.
- Milk-Alkali SyndromeMr. Fischer-Lilja isExperienced. Learn about Milk-Alkali Syndrome.
- Multiple Endocrine NeoplasiaMr. Fischer-Lilja isExperienced. Learn about Multiple Endocrine Neoplasia.
- Multiple Endocrine Neoplasia Type 1Mr. Fischer-Lilja isExperienced. Learn about Multiple Endocrine Neoplasia Type 1.